Literature DB >> 20629131

Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease.

Keith A Josephs1, Jennifer L Whitwell, Bradley F Boeve, David S Knopman, Ronald C Petersen, William T Hu, Joseph E Parisi, Dennis W Dickson, Clifford R Jack.   

Abstract

We compare patterns of gray matter loss on MRI in subjects presenting as corticobasal syndrome (CBS) with Alzheimer disease pathology (CBS-AD) to those presenting as CBS with corticobasal degeneration pathology (CBS-CBD). Voxel-based morphometry was used to compare patterns of gray matter loss in pathologically confirmed CBS-AD subjects (n = 5) and CBS-CBD subjects (n = 6) to a group of healthy controls (n = 20), and to each other. Atlas based parcellation using the automated anatomic labeling atlas was also utilized in a region-of-interest analysis to account for laterality. The CBS-AD subjects were younger at the time of scan when compared with CBS-CBD subjects (median: 60 years vs. 69; P = 0.04). After adjusting for age at time of MRI scan, the CBS-AD subjects showed loss in posterior frontal, temporal, and superior and inferior parietal lobes, while CBS-CBD showed more focal loss predominantly in the posterior frontal lobes when compared with controls. In both CBS-AD and CBS-CBD groups, there was basal ganglia volume loss, yet relative sparing of hippocampi. On direct comparisons between the two subject groups, CBS-AD showed greater loss in both temporal and inferior parietal cortices than CBS-CBD. No regions showed greater loss in the CBS-CBD group compared to the CBS-AD group. These findings persisted when laterality was taken into account. In subjects presenting with CBS, prominent temporoparietal, especially posterior temporal and inferior parietal, atrophy may be a clue to the presence of underlying AD pathology.

Entities:  

Mesh:

Year:  2010        PMID: 20629131      PMCID: PMC2921765          DOI: 10.1002/mds.23062

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  29 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

3.  Imaging correlates of posterior cortical atrophy.

Authors:  Jennifer L Whitwell; Clifford R Jack; Kejal Kantarci; Stephen D Weigand; Bradley F Boeve; David S Knopman; Daniel A Drubach; David F Tang-Wai; Ronald C Petersen; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2006-06-23       Impact factor: 4.673

4.  Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.

Authors:  William T Hu; Gregory W Rippon; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Keith A Josephs
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

5.  Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.

Authors:  P Soliveri; D Monza; D Paridi; D Radice; M Grisoli; D Testa; M Savoiardo; F Girotti
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

6.  Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

Authors:  D W Dickson; C Bergeron; S S Chin; C Duyckaerts; D Horoupian; K Ikeda; K Jellinger; P L Lantos; C F Lippa; S S Mirra; M Tabaton; J P Vonsattel; K Wakabayashi; I Litvan
Journal:  J Neuropathol Exp Neurol       Date:  2002-11       Impact factor: 3.685

7.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory.

Authors:  D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

8.  Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study.

Authors:  Jennifer L Whitwell; Scott A Przybelski; Stephen D Weigand; Robert J Ivnik; Prashanthi Vemuri; Jeffrey L Gunter; Matthew L Senjem; Maria M Shiung; Bradley F Boeve; David S Knopman; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  Brain       Date:  2009-09-17       Impact factor: 13.501

9.  Is the pathology of corticobasal syndrome predictable in life?

Authors:  Bhaskara P Shelley; John R Hodges; Christopher M Kipps; John H Xuereb; Thomas H Bak
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

10.  3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.

Authors:  Jennifer L Whitwell; Scott A Przybelski; Stephen D Weigand; David S Knopman; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2007-05-28       Impact factor: 13.501

View more
  28 in total

1.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

2.  Imaging correlates of pathology in corticobasal syndrome.

Authors:  J L Whitwell; C R Jack; B F Boeve; J E Parisi; J E Ahlskog; D A Drubach; M L Senjem; D S Knopman; R C Petersen; D W Dickson; K A Josephs
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

Review 3.  The corticobasal syndrome-Alzheimer's disease conundrum.

Authors:  Anhar Hassan; Jennifer L Whitwell; Keith A Josephs
Journal:  Expert Rev Neurother       Date:  2011-11       Impact factor: 4.618

4.  Clinicopathological correlations in corticobasal degeneration.

Authors:  Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

Review 5.  Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.

Authors:  Jennifer L Whitwell; Keith A Josephs
Journal:  Nat Rev Neurol       Date:  2012-01-31       Impact factor: 42.937

Review 6.  Biomarkers in frontotemporal lobar degenerations--progress and challenges.

Authors:  William T Hu; John Q Trojanowski; Leslie M Shaw
Journal:  Prog Neurobiol       Date:  2011-04-30       Impact factor: 11.685

7.  Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.

Authors:  Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Robert Reid; Matthew C Baker; Ralph B Perkerson; Val J Lowe; Rosa Rademakers; Clifford R Jack; Keith A Josephs
Journal:  Brain Lang       Date:  2015-02-03       Impact factor: 2.381

8.  Corticobasal syndrome with visual hallucinations and probable REM-sleep behavior disorder: an autopsied case report of a patient with CBD and LBD pathology.

Authors:  George Naasan; Tal Shany-Ur; Manu Sidhu; Cynthia Barton; Robin Ketelle; Suzanne M Shdo; Joel H Kramer; Bruce L Miller; William W Seeley
Journal:  Neurocase       Date:  2019-04-22       Impact factor: 0.881

9.  Progressive apraxic agraphia with micrographia presenting as corticobasal syndrome showing extensive Pittsburgh compound B uptake.

Authors:  Yasuhisa Sakurai; Kenji Ishii; Masahiro Sonoo; Yuko Saito; Shigeo Murayama; Atsushi Iwata; Kensuke Hamada; Izumi Sugimoto; Shoji Tsuji; Toru Mannen
Journal:  J Neurol       Date:  2013-04-16       Impact factor: 4.849

10.  Visuoperception test predicts pathologic diagnosis of Alzheimer disease in corticobasal syndrome.

Authors:  Clara D Boyd; Michael Tierney; Eric M Wassermann; Salvatore Spina; Adrian L Oblak; Bernardino Ghetti; Jordan Grafman; Edward Huey
Journal:  Neurology       Date:  2014-07-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.